News from IVAC - March 2018

March 2018

Commentary: The new typhoid conjugate vaccine marks the dawn of a unique beginning

The news on the prequalification of Typhoid Conjugate Vaccine by the World Health Organization on January 3rd, 2018 and endowment by Gavi have dawned a unique beginning for the entire field of public health. For the first time, a vaccine has been prequalified by WHO that is only needed in the routine immunization programs of of low and middle- income countries in South Asia and Africa.

Read More >
March 2018

Commentary: IVAC’s Newest Mission: Championing Adult Vaccination

Young children and older adults are both at higher risk for potentially devastating and debilitating diseases, many of which are vaccine-preventable. A large portion of countries have failed to address vaccine-preventable diseases like influenza, pneumococcal disease, and herpes zoster (shingles), which affect this fast-growing demographic.

Read More >
March 2018

Commentary: Afghanistan takes important step to prevent a silent killer of children/Rotavirus vaccine for infants could prevent 12,000 deaths in the coming decade

Afghanistan is a country under siege, but one threat doesn’t make the news. The toll is felt among the most vulnerable in an already fragile country. Every year, nearly 5,000 children under five die of rotavirus, a fast-moving and severe form of diarrhea. Afghanistan’s rotavirus death rate is among the highest of any country in Asia.

Read More >